• HUTCHMED (China) filed an updated list of directors with Hong Kong Stock Exchange dated May 13, 2026, showing a nine-member board led by chair and non-executive director Dan Eldar.
• Board includes executive directors Weiguo Su, listed as CEO and chief scientific officer with duties suspended, plus Zefeng Zheng, listed as acting CEO and CFO.
• Renu Bhatia is designated senior and lead independent non-executive director, with Chaohong Hu, Shaowen Chen, plus Dewai Wong also serving as independent non-executive directors.
• Committee roles show Bhatia chairs nomination and remuneration committees, Wong chairs audit committee, Hu chairs technology committee, with other memberships spread across nomination, sustainability, remuneration, plus technology committees.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HUTCHMED (China) Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260513-12157275), on May 13, 2026, and is solely responsible for the information contained therein.